跳至主要内容
临床试验/TCTR20211224003
TCTR20211224003招募中2 期

ow dose VS Moderate dose of Prednisolone in treatment Acute CPPD : The Randomized Controlled Trial

FACULTY OF MEDICINE VAJIRA HOSPITA0 个研究点目标入组 73 人开始时间: 2021年12月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
73

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 100 Years(—)
性别
All

入选标准

  • Patients presented with an acute CPPD attack, and crystal-proven CPP crystal by arthrocentesis

排除标准

  • 1. Secondary cause of CPPD
  • - hemochromatosis
  • - hyperparathyroidism
  • - hypophosphatasia
  • - hypomagnesemia
  • 2. Septic arthritis or Uncontrolled systemic infection
  • 3. DKA or HHS
  • 4. BP >180/110 mmHg
  • 5. Active GI hemorrhage
  • 6. Prior use of colchicine or NSAIDs in past 1 week
  • 7. Neurologic deficit causing decreased pain sensation around the involved joint
  • 8. Intubated
  • 9. Used of corticosteroid due to other indication (such as COPD with acute exacerbation)

研究者

发起方
FACULTY OF MEDICINE VAJIRA HOSPITA

相似试验